Interactions of silica nanoparticles with lung epithelial cells and the association to flotillins

Archives of Toxicology

Volumn 87, Issue 6, 2013, Pages 1053-1065

  Kasper, Jennifer ^a   Hermanns, Maria I ^a   Bantz, Christoph ^b   Koshkina, Olga ^c   Lang, Thomas ^c   Maskos, Michael ^b,c,d   Pohl, Christine ^a   Unger, Ronald E ^a   Kirkpatrick, C James ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c BAM FEDERAL INSTITUTE FOR MATERIALS RESEARCH AND TESTING   (Germany)

^d INSTITUT FÜR MIKROTECHNIK MAINZ GMBH   (Germany)

Author keywords

Alveolar capillary barrier; Cytotoxicity; Endocytosis; Endothelial cells; Flotillin 1; Flotillin 2; Inflammatory response; Lung epithelial cells; Silica nanoparticles

Indexed keywords

CLATHRIN; FLOTILLIN 1; FLOTILLIN 2; INTERLEUKIN 8; LACTATE DEHYDROGENASE; NANOPARTICLE; SILICON DIOXIDE;

ARTICLE; CAVEOLA; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LYSOSOME; MICROVASCULAR ENDOTHELIAL CELL; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; ENDOSOMES; ENDOTHELIAL CELLS; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; L-LACTATE DEHYDROGENASE; LUNG; MEMBRANE PROTEINS; NANOPARTICLES; PARTICLE SIZE; RNA INTERFERENCE; SILICON DIOXIDE; TIME FACTORS; TRANSFECTION;

EID: 84878703492     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0876-5     Document Type: Article

References (33)

1. Ait-Slimane T, Galmes R, Trugnan G, Maurice M (2009) Basolateral internalization of GPI-anchored proteins occurs via a clathrin-independent flotillin-dependent pathway in polarized hepatic cells. Mol Biol Cell 20(17):3792-3800. doi: 10.1091/mbc.E09-04-0275
2. Bailey MM, Berkland CJ (2009) Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 29(1):196-212. doi: 10.1002/med.20140
3. Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdorster E (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3:11. doi: 10.1186/1743-8977-3-11
4. Cho WS, Choi M, Han BS, Cho M, Oh J, Park K, Kim SJ, Kim SH, Jeong J (2007) Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett 175(1-3):24-33
5. Damke H, Baba T, van der Bliek AM, Schmid SL (1995) Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin. J Cell Biol 131(1):69-80
6. Dermine JF, Duclos S, Garin J, St-Louis F, Rea S, Parton RG, Desjardins M (2001) Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes. J Biol Chem 276(21):18507-18512. doi: 10.1074/jbc.M101113200
7. Ellsworth DK, Verhulst D, Spitler TM, Sabacky BJ (2000) Titanium nanoparticles move to the marketplace. Chem Innov 30(12):30-35
8. Glebov OO, Bright NA, Nichols BJ (2006) Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 8(1):46-54. doi: 10.1038/ncb1342
9. Hermanns MI, Kasper J, Dubruel P, Pohl C, Uboldi C, Vermeersch V, Fuchs S, Unger RE, Kirkpatrick CJ (2010) An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction. J R Soc Interface 7(suppl 1):S41-S54. doi: 10.1098/rsif.2009.0288. focus
10. Hetland RB, Schwarze PE, Johansen BV, Myran T, Uthus N, Refsnes M (2001) Silica-induced cytokine release from A549 cells: importance of surface area versus size. Hum Exp Toxicol 20(1):46-55
11. Hoet PH, Bruske-Hohlfeld I, Salata OV (2004) Nanoparticles - known and unknown health risks. J Nanobiotechnology 2(1):12. doi: 10.1186/1477-3155-2-12
12. Institute of Nanotechnology hwnou (2011) Institute of Nanotechnology, http://www.nano.org.uk/
13. Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, Unger RE, Kirkpatrick JC (2011) Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures. Part Fibre Toxicol 8(1):6. doi: 10.1186/1743-8977-8-6
14. Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T (1999) Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release 62(1-2):279-287. doi: S0168-3659(99)00048-6 [pii]
15. Kreyling WG, Semmler-Behnke M, Chaudhry Q (2010) A complementary definition of nanomaterial. Nano Today 5(3):165-168. doi: 10.1016/j.nantod.2010. 03.004
16. Langhorst MF, Reuter A, Jaeger FA, Wippich FM, Luxenhofer G, Plattner H, Stuermer CA (2008) Trafficking of the microdomain scaffolding protein reggie-1/flotillin-2. Eur J Cell Biol 87(4):211-226. doi: 10.1016/j.ejcb.2007. 12.001
17. Li Y, Sun L, Jin M, Du Z, Liu X, Guo C, Huang P, Sun Z (2011) Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol In Vitro. doi: 10.1016/j.tiv.2011.05.003
18. Lison D, Thomassen LC, Rabolli V, Gonzalez L, Napierska D, Seo JW, Kirsch-Volders M, Hoet P, Kirschhock CE, Martens JA (2008) Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol Sci 104(1):155-162
19. Liu Y, Lou C, Yang H, Shi M, Miyoshi H (2011) Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances. Curr Cancer Drug Targets 11(2):156-163. doi: EPub-Abstract-CCDT-96 [pii]
20. Masuzawa M, Fujimura T, Hamada Y, Fujita Y, Hara H, Nishiyama S, Katsuoka K, Tamauchi H, Sakurai Y (1999) Establishment of a human hemangiosarcoma cell line (ISO-HAS). Int J Cancer 81(2):305-308
21. Nabeshi H, Yoshikawa T, Arimori A, Yoshida T, Tochigi S, Hirai T, Akase T, Nagano K, Abe Y, Kamada H, Tsunoda S, Itoh N, Yoshioka Y, Tsutsumi Y (2011) Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res Lett 6(1):93. doi: 10.1186/1556-276X-6-93
22. Napierska D, Thomassen LCJ, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH (2009) Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5(7):846-853. doi: 10.1002/smll.200800461
23. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823-839
24. Service RF (2004) Nanotoxicology: nanotechnology grows up. Science 304(5678):1732-1734
25. Shapero K, Fenaroli F, Lynch I, Cottell DC, Salvati A, Dawson KA (2011) Time and space resolved uptake study of silica nanoparticles by human cells. Mol BioSyst 7(2):371-378. doi: 10.1039/c0mb00109k
26. Sun L, Li Y, Liu X, Jin M, Zhang L, Du Z, Guo C, Huang P, Sun Z (2011) Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol In Vitro. doi: 10.1016/j.tiv.2011.06.012
27. Surti N, Naik S, Bagchi T, Dwarkanath BS, Misra A (2008) Intracellular delivery of nanoparticles of an antiasthmatic drug. AAPS PharmSciTech 9(1):217-223. doi: 10.1208/s12249-008-9036-x
28. Unger RE, Krump-Konvalinkova V, Peters K, Kirkpatrick CJ (2002) In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res 64(3):384-397
29. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS (2010) Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6(18):1952-1967. doi: 10.1002/smll.200901789
30. Walkey CD, Chan WC (2011) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. doi: 10.1039/c1cs15233e
31. Waters KM, Masiello LM, Zangar RC, Tarasevich BJ, Karin NJ, Quesenberry RD, Bandyopadhyay S, Teeguarden JG, Pounds JG, Thrall BD (2009) Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol Sci 107(2):553-569
32. Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y (2005) Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 102(2):373-381. doi: 10.1016/j.jconrel.2004.10.010
33. Zhang Q, Shen Z, Nagai T (2001) Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm 218(1-2):75-80. doi: S0378-5173(01)00614-7 [pii]